Endo International (ENDP) Bonds Trading 1% Lower Analyst
An issue of Endo International PLC (NASDAQ:ENDP) (TSE:ENL) debt fell 1% as a percentage of its face value during trading on Monday after JPMorgan Chase & Co. lowered their price target on the stock from $16.00 to $10.00. The debt issue has a 6% coupon and will mature on July 15, 2023. The debt is now trading at $79.25 and was trading at $79.00 last week. Price moves in a company’s debt in credit markets sometimes predict parallel moves in its share price.
Several other research analysts also recently commented on the company. Leerink Swann downgraded Endo International from an “outperform” rating to a “market perform” rating in a report on Tuesday, March 5th. BidaskClub upgraded Endo International from a “hold” rating to a “buy” rating in a report on Thursday, January 10th. ValuEngine upgraded Endo International from a “strong sell” rating to a “sell” rating in a report on Monday, January 7th. Mizuho decreased their price objective on Endo International to $15.00 and set a “neutral” rating on the stock in a report on Monday, November 26th. Finally, TheStreet downgraded Endo International from a “c-” rating to a “d+” rating in a report on Tuesday, November 27th. Fifteen investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $15.60.
A number of large investors have recently made changes to their positions in the stock. Norges Bank purchased a new position in Endo International during the 4th quarter valued at about $21,218,000. Nordea Investment Management AB increased its holdings in Endo International by 23.0% during the 4th quarter. Nordea Investment Management AB now owns 129,200 shares of the company’s stock valued at $943,000 after purchasing an additional 24,200 shares during the period. Globeflex Capital L P increased its holdings in Endo International by 2.6% during the 4th quarter. Globeflex Capital L P now owns 214,135 shares of the company’s stock valued at $1,563,000 after purchasing an additional 5,391 shares during the period. Municipal Employees Retirement System of Michigan purchased a new position in Endo International during the 4th quarter valued at about $421,000. Finally, LMR Partners LLP purchased a new position in Endo International during the 4th quarter valued at about $442,000. Institutional investors own 92.40% of the company’s stock.
Endo International (NASDAQ:ENDP) (TSE:ENL) last announced its quarterly earnings results on Thursday, February 28th. The company reported $0.75 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.59 by $0.16. Endo International had a negative return on equity of 337.13% and a negative net margin of 35.00%. During the same quarter in the prior year, the firm posted $0.77 EPS. Research analysts expect that Endo International PLC will post 2.17 earnings per share for the current year.
About Endo International (NASDAQ:ENDP)
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals.
Recommended Story: Stochastic Momentum Index (SMI)
Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.